Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients

References

• AlwardWCMedical management of glaucomaN Engl J Med1998339129813079791148
   PubMed Web of Science ®Google Scholar
• Van BuskirkEMFraunfelderFTOcular beta-blockers and systemic effectsAm J Ophthalmol1985986236246149687
   PubMed Web of Science ®Google Scholar
• Van BuskirkEMAdverse reactions from timolol administrationOphthalmology1980874474507402590
   PubMed Web of Science ®Google Scholar
• LamaPJSystemic adverse effects of beta-adrenergic blockers: an evidence-based assessmentAm J Ophthalmol200213474976012429254
   PubMed Web of Science ®Google Scholar
• TorisCBCamrasCBYablonskiMEEffect of PhXA41. A new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyeArch Ophthalmol1993111135113588216015
   PubMedGoogle Scholar
• KonstasAGPMaltezosACGandiSHudginsACStewartWCComparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucomaAm J Ophthalmol1999128152010482089
   PubMed Web of Science ®Google Scholar
• AlmAGriersonIShieldsMBSide effects associated with prostaglandin analog therapySurv Ophthalmol200853S93S10519038628
   PubMed Web of Science ®Google Scholar
• ChenCSWellsJCraigJETopical prostaglandin F(2alpha) analog induced poliosisAm J Ophthalmol200413796596615126178
   PubMed Web of Science ®Google Scholar
• CentofantiMOddoneFChimentiSTangaLCitarellaLManniGPrevention of dermatologic side effects of bimatoprost 0.03% topical therapyAm J Ophthalmol20061421059106017157592
   PubMed Web of Science ®Google Scholar
• CamrasCBHedmanKthe US Latanoprost Study GroupRate of response to latanoprost or timolol in patients with ocular hypertension or glaucomaJ Glaucoma20031246646914646680
   PubMed Web of Science ®Google Scholar
• HigginbothamEJDiestelhorstMPfeifferNRoulandJFAlmAThe efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medicationsSurv Ophthalmol200247S133S14012204710
   PubMed Web of Science ®Google Scholar
• HamacherTSchinzelAScholzel-KlattAShort term efficacy and safety in glaucoma patients chaaged to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monothrapies and adjunctive therapiesBr J Ophthalmol2004881295129815377554
   PubMed Web of Science ®Google Scholar
• FriedenwaldKSCarbonic anhydrase inhibition and aqueous flowAm J Ophthalmol195539596414361606
   PubMed Web of Science ®Google Scholar
• TopperJEBrubakerRFEffects of timolol, epinrphrine, and acetazolamide on aqueous flow during sleepInvest Ophthalmol Vis Sci198526131513194044159
   PubMed Web of Science ®Google Scholar
• IngramCJBrubakerRFEffect of brinzolamide and dorzolamide on aqueous humor flow in human eyesAm J Ophthalmol199912829229610511022
   PubMed Web of Science ®Google Scholar
• TamerCOeksuezHCircadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprostOphthalmic Res200739243117164574
   PubMed Web of Science ®Google Scholar
• CvetkovicRSPerryCMBrinzolamide. A review of its use in the management of primary open-angle glaucoma and ocular hypertensionDrugs Aging20032091994714565787
   PubMed Web of Science ®Google Scholar
• ShojiNOgataNSuyamaHIntraocular pressure lowering effect of brimonidine 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label studyCurr Med Res Opin20052150350815899098
   PubMed Web of Science ®Google Scholar
• AbeKKashiwagiKAdditive effect of brinzolamide on diurnal changes in intraocular pressure in latanoprost-treated eyesOpen Ophthalmol J2008216016419547665
   PubMedGoogle Scholar
• DayDGHollanderDABrimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertensionCurr Med Res Opin200851435144218402717
   PubMed Web of Science ®Google Scholar
• O’ConnorDJMartoneJFMeadAAdditive intraocular pressure lowering effect of various medications with latanoprostAm J Ophthalmol200213383683712036683
   PubMed Web of Science ®Google Scholar
• Martinez-de-la-CasaJMCastilloAGarcia-FeijooJMartinez-HernandezCFernandez-VidalAGarcia-SanchezJConcomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safetyCurr Med Res Opin2004201333133915383180
   PubMed Web of Science ®Google Scholar
• NakamotoKYasudaNEffect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucomaJ Glaucoma20071635235717570997
   PubMed Web of Science ®Google Scholar
• HaraTHaraTTsuruTIncrease of peak intraocular pressure during sleep in reproduced diurnal changes by postureArch Ophthalmol200612416516816476884
   PubMed Web of Science ®Google Scholar
• IwaseASuzukiYAraieMThe Tajimi Study Group, Japan Glaucoma SocietyThe prevalence of primary open-angle glaucoma in JapaneseOphthalmology20041111641164815350316
   PubMed Web of Science ®Google Scholar
• OrzalesiNRossettiLInvernizziTBottoliAAutelitanoAEffect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertensionInvest Ophthalmol Vis Sci2000412566257310937568
   PubMed Web of Science ®Google Scholar
• LiuJHMedeirosFASlightJRWeinrebRNComparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapyOphthalmology200911644945419157559
   PubMed Web of Science ®Google Scholar
• FollmannPPalotásCSüvegesIPetrovitsANocturnal blood pressure and intraocular pressure measurement in glaucoma patients and healthy controlsInt Ophthalmol19961997208387
   Web of Science ®Google Scholar
• LiuJHKripkeDFWeinrebRNComparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressureAm J Ophthalmol200413838939515364220
   PubMed Web of Science ®Google Scholar
• HayrehSSPodhajskyPZimmermanMBBeta-blocker eyedrops and nocturnal arterial hypotensionAm J Ophthalmol199912830130910511024
   PubMed Web of Science ®Google Scholar
• HayrehSSPodhajskyPZimmermanMBRole of nocturnal arteral hypotension in optic nerve head ischemic disordersOphthalmologia19992137696
   Google Scholar
• SilverLHDose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study GroupSurv Ophthalmol200044147153
   Web of Science ®Google Scholar
• MiuraKItoKOkawaCSugimotoKMatsunagaKUjiYComparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprostJ Glaucoma20081723323718414111
   PubMed Web of Science ®Google Scholar
• SieskyBHarrisACantorLBA comparative study of the effects of bronzolamide and doezolamide on retinal oxygen saturation and ocular microcieculation in patients with primary open-angle glaucomaBr J Ophthalmol20089250050418369067
   PubMed Web of Science ®Google Scholar
• LeskeMCWuSYHennisAHokkanenRNemesureBBESs Study GroupRisk factors for incident open-angle glaucoma: the Barbados Eye StudiesOphthalmology2008115859317629563
   PubMed Web of Science ®Google Scholar
• MarchWFOchsnerKIThe long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study GroupAm J Ophthalmol200012913614310682964
   PubMed Web of Science ®Google Scholar
• HerzogEDNeurons and networks in daily rhythmsNat Rev Neurosci2007879080217882255
   PubMed Web of Science ®Google Scholar